**Core Concept**
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are a class of antiretroviral drugs that inhibit the reverse transcriptase enzyme, which is essential for the replication of retroviruses, including HIV. By binding to the reverse transcriptase enzyme, NNRTIs prevent the viral RNA from being converted into DNA, thereby blocking viral replication.

**Why the Correct Answer is Right**
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that acts by binding to the reverse transcriptase enzyme at a site distinct from the polymerase active site. This binding causes a conformational change in the enzyme, resulting in its inactivation. Efavirenz is effective in reducing viral load and preventing the progression of HIV to AIDS. It is often used in combination with other antiretroviral drugs as part of highly active antiretroviral therapy (HAART).

**Why Each Wrong Option is Incorrect**
**Option A:** Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), not an NNRTI. It acts by being phosphorylated and incorporated into the viral DNA, causing chain termination.
**Option C:** Saquinavir is a protease inhibitor (PI), which blocks the protease enzyme responsible for cleaving the viral polyprotein into functional proteins. It is not an NNRTI.
**Option D:** Stavudine is also a nucleoside reverse transcriptase inhibitor (NRTI), similar to zidovudine. It acts by being incorporated into the viral DNA, causing chain termination.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that NNRTIs, like efavirenz, have a high genetic barrier to resistance, meaning that mutations in the reverse transcriptase gene are less likely to occur, making them effective in the long term. However, NNRTIs can cause neuropsychiatric side effects, such as dizziness and depression, especially at higher doses.

✓ Correct Answer: B. Efavirenz